PMID- 26231845 OWN - NLM STAT- MEDLINE DCOM- 20160504 LR - 20181113 IS - 2047-9980 (Electronic) IS - 2047-9980 (Print) IS - 2047-9980 (Linking) VI - 4 IP - 8 DP - 2015 Jul 31 TI - Publication Speed, Reporting Metrics, and Citation Impact of Cardiovascular Trials Supported by the National Heart, Lung, and Blood Institute. PG - e002292 LID - 10.1161/JAHA.115.002292 [doi] LID - e002292 AB - BACKGROUND: We previously demonstrated that cardiovascular (CV) trials funded by the National Heart, Lung, and Blood Institute (NHLBI) were more likely to be published in a timely manner and receive high raw citation counts if they focused on clinical endpoints. We did not examine the metrics of trial reports, and our citation measures were limited by failure to account for topic-related citation behaviors. METHODS AND RESULTS: Of 244 CV trials completed between 2000 and 2011, we identified 184 whose main results were published by August 20, 2014. One investigator who was blinded to rapidity of publication and citation data read each publication and characterized it according to modified Delphi criteria. There were 46 trials (25%) that had Delphi scores of 8 or 9 (of a possible 9); these trials published faster (median time from trial completion to publication, 12.6 [interquartile range IQR, 6.7 to 23.3] vs. 21.8 [IQR, 12.1 to 34.9] months; P<0.01). They also had better normalized citation impact (median citation percentile for topic and date of publication, with 0 best and 100 worst, 1.92 [IQR, 0.64 to 7.83] vs. 8.41 [IQR, 1.80 to 24.75]; P=0.002). By random forest regression, we found that the 3 most important predictors of normalized citation percentile values were total costs, intention-to-treat analyses (as a modified Delphi quality measure), and focus on clinical (not surrogate) endpoints. CONCLUSIONS: NHLBI CV trials were more likely to publish results quickly and yield higher topic-normalized citation impact if they reported results according to well-defined metrics, along with focus on clinical endpoints. CI - (c) 2015 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. FAU - Gordon, David AU - Gordon D AD - Division of Cardiovascular Sciences (DCVS), National Heart, Lung, and Blood Institute (NHLBI), Bethesda, MD (D.G., K.C.A., M.L.). FAU - Cooper-Arnold, Katharine AU - Cooper-Arnold K AD - Division of Cardiovascular Sciences (DCVS), National Heart, Lung, and Blood Institute (NHLBI), Bethesda, MD (D.G., K.C.A., M.L.). FAU - Lauer, Michael AU - Lauer M AD - Division of Cardiovascular Sciences (DCVS), National Heart, Lung, and Blood Institute (NHLBI), Bethesda, MD (D.G., K.C.A., M.L.). LA - eng PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20150731 PL - England TA - J Am Heart Assoc JT - Journal of the American Heart Association JID - 101580524 SB - IM MH - Bibliometrics MH - Cardiology/economics/*statistics & numerical data MH - Cardiovascular Diseases/diagnosis/economics/*therapy MH - Delphi Technique MH - Endpoint Determination MH - Humans MH - Intention to Treat Analysis MH - Journal Impact Factor MH - National Heart, Lung, and Blood Institute (U.S.)/economics/*statistics & numerical data MH - Periodicals as Topic/*statistics & numerical data MH - Publishing/*statistics & numerical data MH - Randomized Controlled Trials as Topic/economics/*statistics & numerical data MH - Research Design/*statistics & numerical data MH - Research Support as Topic/economics/*statistics & numerical data MH - Time Factors MH - Treatment Outcome MH - United States PMC - PMC4599480 OTO - NOTNLM OT - bibliometrics OT - citation OT - public policy OT - randomized, controlled trial OT - research funding EDAT- 2015/08/02 06:00 MHDA- 2016/05/05 06:00 PMCR- 2015/08/01 CRDT- 2015/08/02 06:00 PHST- 2015/08/02 06:00 [entrez] PHST- 2015/08/02 06:00 [pubmed] PHST- 2016/05/05 06:00 [medline] PHST- 2015/08/01 00:00 [pmc-release] AID - JAHA.115.002292 [pii] AID - 10.1161/JAHA.115.002292 [doi] PST - epublish SO - J Am Heart Assoc. 2015 Jul 31;4(8):e002292. doi: 10.1161/JAHA.115.002292.